{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:23Z","timestamp":1792097363270,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Instituto de Salud Carlos III with the support of the European Regional Development Fund","award":["ISCIII JR22\/00011"],"award-info":[{"award-number":["ISCIII JR22\/00011"]}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"DOI":"10.1007\/s11920-026-01688-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:48:05Z","timestamp":1781156885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Pharmacological and Psychological Treatments on Depressive Symptoms in Body Dysmorphic Disorder: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"Alvaro","family":"Loewen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Pe\u00f1uelas-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Alacreu-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jim\u00e9nez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Grijalba-Chiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mata-Iturralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Porras-Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1688_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"1","key":"1688_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-024-00577-z","volume":"10","author":"C R\u00fcck","year":"2024","unstructured":"R\u00fcck C, Mataix-Cols D, Feusner JD, Shavitt RG, Veale D, Krebs G, et al. Body dysmorphic disorder. Nat Rev Dis Primers. 2024;10(1):92. https:\/\/doi.org\/10.1038\/s41572-024-00577-z.","journal-title":"Nat Rev Dis Primers"},{"key":"1688_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bodyim.2016.07.003","volume":"18","author":"D Veale","year":"2016","unstructured":"Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image. 2016;18:168\u201386. https:\/\/doi.org\/10.1016\/j.bodyim.2016.07.003.","journal-title":"Body Image"},{"issue":"1","key":"1688_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bodyim.2007.11.002","volume":"5","author":"JD Feusner","year":"2008","unstructured":"Feusner JD, Yaryura-Tobias J, Saxena S. The pathophysiology of body dysmorphic disorder. Body Image. 2008;5(1):3\u201312. https:\/\/doi.org\/10.1016\/j.bodyim.2007.11.002.","journal-title":"Body Image"},{"issue":"4","key":"1688_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.comppsych.2004.10.004","volume":"46","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005;46(4):254\u201360. https:\/\/doi.org\/10.1016\/j.comppsych.2004.10.004.","journal-title":"Compr Psychiatry"},{"key":"1688_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cpr.2016.08.002","volume":"49","author":"I Angelakis","year":"2016","unstructured":"Angelakis I, Gooding PA, Panagioti M. Suicidality in body dysmorphic disorder (BDD): a systematic review with meta-analysis. Clin Psychol Rev. 2016;49:55\u201366. https:\/\/doi.org\/10.1016\/j.cpr.2016.08.002.","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"1688_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1022090200057","volume":"70","author":"KA Phillips","year":"1999","unstructured":"Phillips KA. Body dysmorphic disorder and depression: theoretical considerations and treatment strategies. Psychiatr Q. 1999;70(4):313\u201331. https:\/\/doi.org\/10.1023\/A:1022090200057.","journal-title":"Psychiatr Q"},{"key":"1688_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jad.2019.11.011","volume":"262","author":"BJ Summers","year":"2020","unstructured":"Summers BJ, Aalbers G, Jones PJ, McNally RJ, Phillips KA, Wilhelm S. A network perspective on body dysmorphic disorder and major depressive disorder. J Affect Disord. 2020;262:165\u201373. https:\/\/doi.org\/10.1016\/j.jad.2019.11.011.","journal-title":"J Affect Disord"},{"key":"1688_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bodyim.2016.09.007","volume":"19","author":"AM Shaw","year":"2016","unstructured":"Shaw AM, Arditte Hall KA, Rosenfield E, Timpano KR. Body dysmorphic disorder symptoms and risk for suicide: the role of depression. Body Image. 2016;19:169\u201374. https:\/\/doi.org\/10.1016\/j.bodyim.2016.09.007.","journal-title":"Body Image"},{"issue":"6","key":"1688_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S109285290001796X","volume":"7","author":"KA Phillips","year":"2002","unstructured":"Phillips KA. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectr. 2002;7(6):453\u201363. https:\/\/doi.org\/10.1017\/S109285290001796X.","journal-title":"CNS Spectr"},{"issue":"8","key":"1688_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2174\/1570159X16666180426153940","volume":"17","author":"K Hong","year":"2019","unstructured":"Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Pharmacological treatment of body dysmorphic disorder. Curr Neuropharmacol. 2019;17(8):697\u2013702. https:\/\/doi.org\/10.2174\/1570159X16666180426153940.","journal-title":"Curr Neuropharmacol"},{"key":"1688_CR12","doi-asserted-by":"publisher","unstructured":"Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev. 2009(1). https:\/\/doi.org\/10.1002\/14651858.CD005332.pub2.","DOI":"10.1002\/14651858.CD005332.pub2"},{"issue":"1","key":"1688_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.brat.2004.12.006","volume":"44","author":"J Williams","year":"2006","unstructured":"Williams J, Hadjistavropoulos T, Sharpe D. A meta-analysis of psychological and pharmacological treatments for body dysmorphic disorder. Behav Res Ther. 2006;44(1):99\u2013111. https:\/\/doi.org\/10.1016\/j.brat.2004.12.006.","journal-title":"Behav Res Ther"},{"key":"1688_CR14","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"BMJ"},{"key":"1688_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","volume":"74","author":"A Jelicic Kadic","year":"2016","unstructured":"Jelicic Kadic A, Vucic K, Dosenovic S, Sapunar D, Puljak L. Extracting data from figures with software was faster, with higher interrater reliability than manual extraction. J Clin Epidemiol. 2016;74:119\u201323. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.002.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"1688_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005923","volume":"4","author":"J Enander","year":"2014","unstructured":"Enander J, Ivanov VZ, Andersson E, Mataix-Cols D, Lj\u00f3tsson B, R\u00fcck C. Therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study. BMJ Open. 2014;4(9):e005923. https:\/\/doi.org\/10.1136\/bmjopen-2014-005923.","journal-title":"BMJ Open"},{"key":"1688_CR17","doi-asserted-by":"publisher","first-page":"i241","DOI":"10.1136\/bmj.i241","volume":"352","author":"J Enander","year":"2016","unstructured":"Enander J, Andersson E, Mataix-Cols D, Lichtenstein L, Alstr\u00f6 K, Andersson G, et al. Therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder: single-blind randomised controlled trial. BMJ. 2016;352:i241. https:\/\/doi.org\/10.1136\/bmj.i241.","journal-title":"BMJ"},{"issue":"1","key":"1688_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55\u201379. https:\/\/doi.org\/10.1002\/jrsm.1164.","journal-title":"Res Synth Methods"},{"issue":"17","key":"1688_CR19","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/sim.1482","volume":"22","author":"G Knapp","year":"2003","unstructured":"Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22(17):2693\u2013710. https:\/\/doi.org\/10.1002\/sim.1482.","journal-title":"Stat Med"},{"issue":"2","key":"1688_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112\u201325. https:\/\/doi.org\/10.1002\/jrsm.11.","journal-title":"Res Synth Methods"},{"issue":"2","key":"1688_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/J.0006-341X.2000.00455.X","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363. https:\/\/doi.org\/10.1111\/J.0006-341X.2000.00455.X.","journal-title":"Biometrics"},{"issue":"10","key":"1688_CR22","doi-asserted-by":"publisher","first-page":"e0164898","DOI":"10.1371\/journal.pone.0164898","volume":"11","author":"A Musekiwa","year":"2016","unstructured":"Musekiwa A, Manda SO, Mwambi HG, Chen DG. Meta-analysis of effect sizes reported at multiple time points using general linear mixed model. PLoS ONE. 2016;11(10):e0164898. https:\/\/doi.org\/10.1371\/journal.pone.0164898.","journal-title":"PLoS ONE"},{"key":"1688_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1688_CR24","volume-title":"Cochrane handbook for systematic reviews of interventions","year":"2008","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons; 2008."},{"issue":"2","key":"1688_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2522\/ptj.20070147","volume":"88","author":"SA Olivo","year":"2008","unstructured":"Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther. 2008;88(2):156\u201375. https:\/\/doi.org\/10.2522\/ptj.20070147.","journal-title":"Phys Ther"},{"key":"1688_CR26","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2012. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"3","key":"1688_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.11124\/JBIES-22-00125","volume":"21","author":"TH Barker","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023;21(3):478\u201393. https:\/\/doi.org\/10.11124\/JBIES-22-00125.","journal-title":"JBI Evid Synth"},{"issue":"6","key":"1688_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000360740","volume":"83","author":"D Veale","year":"2014","unstructured":"Veale D, Anson M, Miles S, Pieta M, Costa A, Ellison N. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial. Psychother Psychosom. 2014;83(6):341\u201353. https:\/\/doi.org\/10.1159\/000360740.","journal-title":"Psychother Psychosom"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"101869","DOI":"10.1016\/j.jbtep.2023.101869","volume":"81","author":"YQ Gu","year":"2023","unstructured":"Gu YQ, Zhu Y. A randomized controlled trial of mindfulness-based cognitive therapy for body dysmorphic disorder: impact on core symptoms, emotion dysregulation, and executive functioning. J Behav Ther Exp Psychiatry. 2023;81:101869. https:\/\/doi.org\/10.1016\/j.jbtep.2023.101869.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"1","key":"1688_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0005-7967(96)00082-4","volume":"35","author":"D McKay","year":"1997","unstructured":"McKay D, Todaro J, Neziroglu F, Campisi T, Moritz EK, Yaryura-Tobias JA. Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav Res Ther. 1997;35(1):67\u201370. https:\/\/doi.org\/10.1016\/S0005-7967(96)00082-4.","journal-title":"Behav Res Ther"},{"issue":"4","key":"1688_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/0145445599234006","volume":"23","author":"D McKay","year":"1999","unstructured":"McKay D. Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif. 1999;23(4):620\u20139. https:\/\/doi.org\/10.1177\/0145445599234006.","journal-title":"Behav Modif"},{"key":"1688_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpsychires.2023.03.031","volume":"161","author":"FR Schneier","year":"2023","unstructured":"Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, et al. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. J Psychiatr Res. 2023;161:364\u201370. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.03.031.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"1688_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/archpsyc.56.11.1033","volume":"56","author":"E Hollander","year":"1999","unstructured":"Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56(11):1033\u20139. https:\/\/doi.org\/10.1001\/archpsyc.56.11.1033.","journal-title":"Arch Gen Psychiatry"},{"key":"1688_CR34","unstructured":"Wilhelm S. Effectiveness of levetiracetam in the treatment of body dysmorphic disorder. ClinicalTrials.gov identifier: NCT00265109. Updated August 29, 2019."},{"issue":"5","key":"1688_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1017\/S1092852900025414","volume":"14","author":"KA Phillips","year":"2009","unstructured":"Phillips KA, Menard W. A prospective pilot study of levetiracetam for body dysmorphic disorder. CNS Spectr. 2009;14(5):252\u201360. https:\/\/doi.org\/10.1017\/S1092852900025414.","journal-title":"CNS Spectr"},{"issue":"2","key":"1688_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S1092852900016291","volume":"13","author":"A Allen","year":"2008","unstructured":"Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, et al. An open-label trial of venlafaxine in body dysmorphic disorder. CNS Spectr. 2008;13(2):138\u201344. https:\/\/doi.org\/10.1017\/S1092852900016291.","journal-title":"CNS Spectr"},{"issue":"4","key":"1688_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/archpsyc.59.4.381","volume":"59","author":"KA Phillips","year":"2002","unstructured":"Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59(4):381\u20138. https:\/\/doi.org\/10.1001\/archpsyc.59.4.381.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"1688_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/YIC.0b013e32831db2e9","volume":"24","author":"KA Phillips","year":"2009","unstructured":"Phillips KA, Kelly MM. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. Int Clin Psychopharmacol. 2009;24(1):26\u20138. https:\/\/doi.org\/10.1097\/YIC.0b013e32831db2e9.","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"1688_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00004850-199612000-00006","volume":"11","author":"G Perugi","year":"1996","unstructured":"Perugi G, Giannotti D, Di Vaio S, Frare F, Saettoni M, Cassano GB. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol. 1996;11(4):247\u201354. https:\/\/doi.org\/10.1097\/00004850-199612000-00006.","journal-title":"Int Clin Psychopharmacol"},{"key":"1688_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jad.2018.11.058","volume":"245","author":"B Mohajerin","year":"2019","unstructured":"Mohajerin B, Bakhtiyar M, Olesnycky OS, Dolatshahi B, Motabi F. Application of a transdiagnostic treatment for emotional disorders to body dysmorphic disorder: a randomized controlled trial. J Affect Disord. 2019;245:637\u201344. https:\/\/doi.org\/10.1016\/j.jad.2018.11.058.","journal-title":"J Affect Disord"},{"key":"1688_CR41","doi-asserted-by":"publisher","first-page":"100781","DOI":"10.1016\/j.jocrd.2023.100781","volume":"36","author":"EE Bernstein","year":"2023","unstructured":"Bernstein EE, Weingarden H, Greenberg JL, Williams J, Hoeppner SS, Snorrason I, et al. Credibility and expectancy of smartphone-based cognitive behavioral therapy among adults with body dysmorphic disorder. J Obsessive Compuls Relat Disord. 2023;36:100781. https:\/\/doi.org\/10.1016\/j.jocrd.2023.100781.","journal-title":"J Obsessive Compuls Relat Disord"},{"issue":"8","key":"1688_CR42","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1017\/S0033291721005390","volume":"53","author":"JE Curtiss","year":"2023","unstructured":"Curtiss JE, Bernstein EE, Wilhelm S, Phillips KA. Predictors of pharmacotherapy outcomes for body dysmorphic disorder: a machine learning approach. Psychol Med. 2023;53(8):3366\u201376. https:\/\/doi.org\/10.1017\/S0033291721005390.","journal-title":"Psychol Med"},{"issue":"2","key":"1688_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.beth.2015.10.009","volume":"47","author":"JL Greenberg","year":"2016","unstructured":"Greenberg JL, Mothi SS, Wilhelm S. Cognitive-behavioral therapy for adolescent body dysmorphic disorder: a pilot study. Behav Ther. 2016;47(2):213\u201324. https:\/\/doi.org\/10.1016\/j.beth.2015.10.009.","journal-title":"Behav Ther"},{"key":"1688_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jad.2024.03.044","volume":"355","author":"JL Greenberg","year":"2024","unstructured":"Greenberg JL, Weingarden H, Hoeppner SS, Berger-Gutierrez RM, Klare D, Snorrason I, et al. Predicting response to a smartphone-based cognitive-behavioral therapy for body dysmorphic disorder. J Affect Disord. 2024;355:106\u201314. https:\/\/doi.org\/10.1016\/j.jad.2024.03.044.","journal-title":"J Affect Disord"},{"issue":"4","key":"1688_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1521\/ijct.2011.4.4.363","volume":"4","author":"S Khemlani-Patel","year":"2011","unstructured":"Khemlani-Patel S, Neziroglu F, Mancusi LM. Cognitive-behavioral therapy for body dysmorphic disorder: a comparative investigation. Int J Cogn Ther. 2011;4(4):363\u201377. https:\/\/doi.org\/10.1521\/ijct.2011.4.4.363.","journal-title":"Int J Cogn Ther"},{"issue":"4","key":"1688_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.beth.2017.01.001","volume":"48","author":"G Krebs","year":"2017","unstructured":"Krebs G, Fern\u00e1ndez de la Cruz L, Monzani B, Bowyer L, Anson M, Cadman J, et al. Long-term outcomes of cognitive-behavioral therapy for adolescent body dysmorphic disorder. Behav Ther. 2017;48(4):462\u201373. https:\/\/doi.org\/10.1016\/j.beth.2017.01.001.","journal-title":"Behav Ther"},{"issue":"5","key":"1688_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.beth.2022.04.010","volume":"53","author":"D Rautio","year":"2022","unstructured":"Rautio D, Gumpert M, Jassi A, Krebs G, Flygare O, Andr\u00e9n P, et al. Effectiveness of multimodal treatment for young people with body dysmorphic disorder in two specialist clinics. Behav Ther. 2022;53(5):1037\u201349. https:\/\/doi.org\/10.1016\/j.beth.2022.04.010.","journal-title":"Behav Ther"},{"issue":"6","key":"1688_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.beth.2015.06.003","volume":"46","author":"D Veale","year":"2015","unstructured":"Veale D, Miles S, Anson M. Long-term outcome of cognitive behavior therapy for body dysmorphic disorder: a naturalistic case series of 1 to 4 years after a controlled trial. Behav Ther. 2015;46(6):775\u201385. https:\/\/doi.org\/10.1016\/j.beth.2015.06.003.","journal-title":"Behav Ther"},{"issue":"3","key":"1688_CR49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1037\/ccp0000372","volume":"87","author":"NL Wilver","year":"2019","unstructured":"Wilver NL, Cougle JR. An internet-based controlled trial of interpretation bias modification versus progressive muscle relaxation for body dysmorphic disorder. J Consult Clin Psychol. 2019;87(3):257\u201369. https:\/\/doi.org\/10.1037\/ccp0000372.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"1688_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12888-020-02655-4","volume":"20","author":"O Flygare","year":"2020","unstructured":"Flygare O, Enander J, Andersson E, Lj\u00f3tsson B, Ivanov VZ, Mataix-Cols D, et al. Predictors of remission from body dysmorphic disorder after internet-delivered cognitive behavior therapy: a machine learning approach. BMC Psychiatry. 2020;20(1):247. https:\/\/doi.org\/10.1186\/s12888-020-02655-4.","journal-title":"BMC Psychiatry"},{"key":"1688_CR51","doi-asserted-by":"publisher","DOI":"10.2196\/55283","volume":"11","author":"C Kerry","year":"2024","unstructured":"Kerry C, Mann P, Babaei N, Katz J, Pirbaglou M, Ritvo P. Web-based therapist-guided mindfulness-based cognitive behavioral therapy for body dysmorphic disorder: pilot randomized controlled trial. JMIR Ment Health. 2024;11:e55283. https:\/\/doi.org\/10.2196\/55283.","journal-title":"JMIR Ment Health"},{"issue":"5","key":"1688_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1176\/appi.psy.45.5.438","volume":"45","author":"KA Phillips","year":"2004","unstructured":"Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics. 2004;45(5):438\u201344. https:\/\/doi.org\/10.1176\/appi.psy.45.5.438.","journal-title":"Psychosomatics"},{"key":"1688_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/da.23148","author":"H Weingarden","year":"2021","unstructured":"Weingarden H, Hoeppner SS, Snorrason I, Greenberg JL, Phillips KA, Wilhelm S. Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder. Depress Anxiety. 2021. https:\/\/doi.org\/10.1002\/da.23148.","journal-title":"Depress Anxiety"},{"issue":"3","key":"1688_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.beth.2013.12.007","volume":"45","author":"S Wilhelm","year":"2014","unstructured":"Wilhelm S, Phillips KA, Didie E, Buhlmann U, Greenberg JL, Fama JM, et al. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behav Ther. 2014;45(3):314\u201327. https:\/\/doi.org\/10.1016\/j.beth.2013.12.007.","journal-title":"Behav Ther"},{"issue":"4","key":"1688_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamapsychiatry.2018.4156","volume":"76","author":"S Wilhelm","year":"2019","unstructured":"Wilhelm S, Phillips KA, Greenberg JL, O\u2019Keefe SM, Hoeppner SS, Keshaviah A, et al. Efficacy and posttreatment effects of therapist-delivered cognitive behavioral therapy vs supportive psychotherapy for adults with body dysmorphic disorder: a randomized clinical trial. JAMA Psychiatry. 2019;76(4):363\u201373. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.4156.","journal-title":"JAMA Psychiatry"},{"key":"1688_CR56","unstructured":"Wilhelm S. Waitlist-control trial of smartphone cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD). ClinicalTrials.gov identifier: NCT03673046. Updated Oct 7, 2022."},{"issue":"3","key":"1688_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024693","volume":"9","author":"AJ Gentile","year":"2019","unstructured":"Gentile AJ, La Lima C, Flygare O, Enander J, Wilhelm S, Mataix-Cols D, et al. Internet-based, therapist-guided cognitive-behavioural therapy for body dysmorphic disorder with global eligibility for inclusion: an uncontrolled pilot study. BMJ Open. 2019;9(3):e024693. https:\/\/doi.org\/10.1136\/bmjopen-2018-024693.","journal-title":"BMJ Open"},{"issue":"4","key":"1688_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.beth.2018.12.008","volume":"50","author":"JL Greenberg","year":"2019","unstructured":"Greenberg JL, Phillips KA, Steketee G, Hoeppner SS, Wilhelm S. Predictors of response to cognitive-behavioral therapy for body dysmorphic disorder. Behav Ther. 2019;50(4):839\u201349. https:\/\/doi.org\/10.1016\/j.beth.2018.12.008.","journal-title":"Behav Ther"},{"issue":"11","key":"1688_CR59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaac.2015.08.011","volume":"54","author":"D Mataix-Cols","year":"2015","unstructured":"Mataix-Cols D, Fern\u00e1ndez de la Cruz L, Isomura K, Anson M, Turner C, Monzani B, et al. A pilot randomized controlled trial of cognitive-behavioral therapy for adolescents with body dysmorphic disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(11):895\u2013904. https:\/\/doi.org\/10.1016\/j.jaac.2015.08.011.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"1688_CR60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4088\/JCP.v64n0615","volume":"64","author":"KA Phillips","year":"2003","unstructured":"Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64(6):715\u201320. https:\/\/doi.org\/10.4088\/JCP.v64n0615.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1688_CR61","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.162.2.377","volume":"162","author":"KA Phillips","year":"2005","unstructured":"Phillips KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162(2):377\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.162.2.377.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1688_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.yic.0000194378.65460.ef","volume":"21","author":"KA Phillips","year":"2006","unstructured":"Phillips KA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006;21(3):177\u20139. https:\/\/doi.org\/10.1097\/01.yic.0000194378.65460.ef.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"1688_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.beth.2022.07.006","volume":"54","author":"V Ritter","year":"2023","unstructured":"Ritter V, Sch\u00fcller J, Berkmann EM, von Soosten-H\u00f6llings-Lilge L, Stangier U. Efficacy of cognitive therapy for body dysmorphic disorder: a randomized controlled pilot trial. Behav Ther. 2023;54(1):65\u201376. https:\/\/doi.org\/10.1016\/j.beth.2022.07.006.","journal-title":"Behav Ther"},{"key":"1688_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brat.2016.09.005","volume":"87","author":"BJ Summers","year":"2016","unstructured":"Summers BJ, Cougle JR. Modifying interpretation biases in body dysmorphic disorder: evaluation of a brief computerized treatment. Behav Res Ther. 2016;87:117\u201327. https:\/\/doi.org\/10.1016\/j.brat.2016.09.005.","journal-title":"Behav Res Ther"},{"issue":"9","key":"1688_CR65","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0005-7967(96)00025-3","volume":"34","author":"D Veale","year":"1996","unstructured":"Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996;34(9):717\u201329. https:\/\/doi.org\/10.1016\/0005-7967(96)00025-3.","journal-title":"Behav Res Ther"},{"issue":"5","key":"1688_CR66","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10608-019-10015-0","volume":"43","author":"H Weingarden","year":"2019","unstructured":"Weingarden H, Mothi SS, Ladis I, Hoeppner S, Reese HE, Timpano K, et al. D-cycloserine-augmented behavior therapy for body dysmorphic disorder: a preliminary efficacy trial. Cognit Ther Res. 2019;43(5):937\u201347. https:\/\/doi.org\/10.1007\/s10608-019-10015-0.","journal-title":"Cognit Ther Res"},{"issue":"1","key":"1688_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0005-7967(98)00109-0","volume":"37","author":"S Wilhelm","year":"1999","unstructured":"Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther. 1999;37(1):71\u20135. https:\/\/doi.org\/10.1016\/S0005-7967(98)00109-0.","journal-title":"Behav Res Ther"},{"issue":"4","key":"1688_CR68","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.beth.2011.02.002","volume":"42","author":"S Wilhelm","year":"2011","unstructured":"Wilhelm S, Phillips KA, Fama JM, Greenberg JL, Steketee G. Modular cognitive-behavioral therapy for body dysmorphic disorder. Behav Ther. 2011;42(4):624\u201333. https:\/\/doi.org\/10.1016\/j.beth.2011.02.002.","journal-title":"Behav Ther"},{"issue":"1","key":"1688_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.beth.2019.03.007","volume":"51","author":"S Wilhelm","year":"2020","unstructured":"Wilhelm S, Weingarden H, Greenberg JL, McCoy TH, Ladis I, Summers BJ, et al. Development and pilot testing of a cognitive-behavioral therapy digital service for body dysmorphic disorder. Behav Ther. 2020;51(1):15\u201326. https:\/\/doi.org\/10.1016\/j.beth.2019.03.007.","journal-title":"Behav Ther"},{"issue":"4","key":"1688_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000524628","volume":"91","author":"S Wilhelm","year":"2022","unstructured":"Wilhelm S, Weingarden H, Greenberg JL, Hoeppner SS, Snorrason I, Bernstein EE, et al. Efficacy of app-based cognitive behavioral therapy for body dysmorphic disorder with coach support: initial randomized controlled clinical trial. Psychother Psychosom. 2022;91(4):277\u201385. https:\/\/doi.org\/10.1159\/000524628.","journal-title":"Psychother Psychosom"},{"issue":"4","key":"1688_CR71","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4088\/JCP.v59n0404","volume":"59","author":"KA Phillips","year":"1998","unstructured":"Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59(4):165\u201371. https:\/\/doi.org\/10.4088\/JCP.v59n0404.","journal-title":"J Clin Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-026-01688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-026-01688-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-026-01688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:48:07Z","timestamp":1781156887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-026-01688-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1007\/s11920-026-01688-y","relation":{},"ISSN":["1535-1645"],"issn-type":[{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}